Letter to the EditorGene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia
Section snippets
Conflict of interest statement
The authors also declare that they have no competing interests.
Acknowledgements
Sources of support: FAPEMIG, CNPq, and BioGenetics.
References (4)
- et al.
The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia
Cancer Detect Prev
(2006) - et al.
Statistical issues with microarrays: processing and analysis
Trends Genet
(2002)
There are more references available in the full text version of this article.
Cited by (9)
Platform-independent approach for cancer detection from gene expression profiles of peripheral blood cells
2020, Briefings in BioinformaticsContribution of Nitric oxide synthase 3 genetic variants to nasopharyngeal carcinoma risk and progression in a Tunisian population
2019, European Archives of Oto-Rhino-LaryngologyMulti-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma Case Control Study
2018, World Journal of GastroenterologyWidespread telomere instability in prostatic lesions
2016, Molecular CarcinogenesisEndothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in serbian population
2013, International Journal of Experimental Pathology
Copyright © 2008 Elsevier Ltd. All rights reserved.